EQL Pharma AB (publ) (STO:EQL)
Sweden flag Sweden · Delayed Price · Currency is SEK
55.50
+0.30 (0.54%)
At close: Mar 6, 2026

EQL Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
1,6392,0641,2291,087974994
Upgrade
Market Cap Growth
-32.87%67.85%13.10%11.64%-2.05%153.33%
Upgrade
Enterprise Value
2,0032,2051,3171,0751,010980
Upgrade
Last Close Price
55.5071.0042.3037.4033.5034.20
Upgrade
PE Ratio
56.6547.8554.1535.1530.8695.88
Upgrade
PS Ratio
3.855.534.654.182.385.55
Upgrade
PB Ratio
6.079.346.927.027.8810.90
Upgrade
P/TBV Ratio
--42.9120.8238.62-
Upgrade
P/FCF Ratio
---40.0223.6316.67
Upgrade
P/OCF Ratio
---39.3623.2816.55
Upgrade
EV/Sales Ratio
4.715.904.994.142.475.47
Upgrade
EV/EBITDA Ratio
22.9929.1433.9422.7024.9259.15
Upgrade
EV/EBIT Ratio
30.1032.7340.3826.0126.0185.05
Upgrade
EV/FCF Ratio
-160.26--39.5924.5216.43
Upgrade
Debt / Equity Ratio
1.622.060.680.430.620.96
Upgrade
Debt / EBITDA Ratio
5.025.882.981.371.835.26
Upgrade
Debt / FCF Ratio
---2.451.851.46
Upgrade
Net Debt / Equity Ratio
1.351.690.560.140.280.66
Upgrade
Net Debt / EBITDA Ratio
4.274.932.570.470.863.66
Upgrade
Net Debt / FCF Ratio
-29.15-12.13-8.060.820.851.02
Upgrade
Asset Turnover
0.670.630.800.991.861.09
Upgrade
Inventory Turnover
1.391.531.742.697.473.62
Upgrade
Quick Ratio
1.030.970.530.830.770.56
Upgrade
Current Ratio
2.161.811.221.431.251.03
Upgrade
Return on Equity (ROE)
12.28%21.63%13.66%22.21%29.37%12.04%
Upgrade
Return on Assets (ROA)
6.53%7.12%6.18%9.87%11.00%4.39%
Upgrade
Return on Invested Capital (ROIC)
8.35%12.26%11.40%19.56%21.96%9.19%
Upgrade
Return on Capital Employed (ROCE)
10.40%11.50%15.40%24.50%27.90%10.60%
Upgrade
Earnings Yield
1.79%2.09%1.85%2.84%3.24%1.04%
Upgrade
FCF Yield
-0.76%-1.49%-1.01%2.50%4.23%6.00%
Upgrade
Buyback Yield / Dilution
-0.22%-0.34%-0.91%-1.59%-3.37%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.